Vitamin D

Disclaimer: The information presented in this section is for educational and informational purposes only. It is not intended as medical advice. No supplement discussed on this site has been proven to prevent, stop, or reverse neurodegenerative disease. While some supplements have been studied for their potential to support aspects of cellular function, any observed effects are generally modest, variable between individuals, and highly context-dependent. Before starting any supplement, consult with a qualified healthcare professional. Appropriate professionals may include a physician, neurologist, pharmacist, nurse practitioner, physician assistant, or registered dietitian. This does not refer to wellness influencers, supplement sellers, health coaches, or practitioners without medical training in pharmacology, neurology, and drug-supplement interactions. Supplements may interact with medications or produce unintended side effects. The inclusion of any supplement on this site does not constitute a recommendation for use. Descriptions of mechanisms or research findings are provided to improve understanding of current scientific investigation, not to guide individual treatment decisions.

Overview

Vitamin D is a fat-soluble hormone precursor involved in bone health, immune signaling, and calcium regulation, that has also been widely promoted for brain aging and dementia prevention. In neurodegeneration, claims usually focus on lower dementia risk, slower cognitive decline, or support of brain resilience.

The most accurate framing is that vitamin D is important to correct when deficient, but that supplementing it beyond that has not clearly emerged as a proven neurodegeneration intervention.

Proposed Mechanisms

Proposed mechanisms include effects on immune modulation, inflammation, neuronal calcium handling, and possibly neurotrophic support. Observationally, low vitamin D levels are associated with higher risk of cognitive decline and dementia, which gives the hypothesis credibility.

However, association is not the same as treatment effect; correlation doesn’t equal causation. Low vitamin D may partly reflect poorer general health, lower outdoor activity, frailty, or early disease processes as opposed to acting as a direct causal driver.

Evidence Summary

Preclinical: Animal and mechanistic data often support neuroprotective roles for vitamin D in inflammation and neuronal stress models. That gives the category a reasonable preclinical basis.

Translational / RCT / observational: Human evidence is split. Observational meta-analyses continue to show that lower vitamin D status is associated with higher dementia risk, but recent randomized trials have been disappointing. A 2025 cognition trial in older adults with mild-to-moderate deficiency found no measurable cognitive benefit, and a 2025 five-year randomized trial found no reduction in dementia incidence in a largely vitamin D-sufficient older population.

Evidence level

Low for disease modification; moderate for correcting deficiency as good general care.

Vitamin D deficiency should be addressed for overall health, but the evidence does not currently support presenting vitamin D supplementation as a proven way to prevent or slow neurodegeneration in otherwise sufficient adults.

Limitations

The main limitation is the gap between observational association and randomized intervention. People with higher vitamin D levels are often healthier in many other ways. Trials also depend heavily on baseline deficiency status, dose, adherence, and duration.

Safety and Considerations

Vitamin D is generally safe at standard replacement doses, but excessive intake can cause hypercalcemia and related complications.

Sources

Huang Y et al. “Association of vitamin D with risk of dementia: a dose-response meta-analysis.” 2025.
Corbett A et al. “Impact of Vitamin D Supplementation on Cognition in Older Adults With Mild-to-Moderate Vitamin D Deficiency.” 2025.
Lönnroos E et al. “The Effect of Vitamin D3 Supplementation on the Incidence of Dementia.” 2025.